144 related articles for article (PubMed ID: 17295355)
1. A proteomic investigation of glomerular podocytes from a Denys-Drash syndrome patient with a mutation in the Wilms tumour suppressor gene WT1.
Viney RL; Morrison AA; van den Heuvel LP; Ni L; Mathieson PW; Saleem MA; Ladomery MR
Proteomics; 2007 Mar; 7(5):804-15. PubMed ID: 17295355
[TBL] [Abstract][Full Text] [Related]
2. Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.
Schumacher VA; Jeruschke S; Eitner F; Becker JU; Pitschke G; Ince Y; Miner JH; Leuschner I; Engers R; Everding AS; Bulla M; Royer-Pokora B
J Am Soc Nephrol; 2007 Mar; 18(3):719-29. PubMed ID: 17267748
[TBL] [Abstract][Full Text] [Related]
3. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
4. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA
J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137
[TBL] [Abstract][Full Text] [Related]
5. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
[TBL] [Abstract][Full Text] [Related]
6. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
Morrison AA; Viney RL; Saleem MA; Ladomery MR
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
[TBL] [Abstract][Full Text] [Related]
7. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N
Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585
[TBL] [Abstract][Full Text] [Related]
8. Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome.
Swiatecka-Urban A; Mokrzycki MH; Kaskel F; Da Silva F; Denamur E
Pediatr Nephrol; 2001 Aug; 16(8):627-30. PubMed ID: 11519891
[TBL] [Abstract][Full Text] [Related]
9. A novel WT1 gene mutation in a chinese girl with denys-drash syndrome.
Wang F; Cai J; Wang J; He M; Mao J; Zhu K; Zhao M; Guan Z; Li L; Jin H; Shu Q
J Clin Lab Anal; 2021 May; 35(5):e23769. PubMed ID: 33942367
[TBL] [Abstract][Full Text] [Related]
10. A familial WT1 mutation associated with incomplete Denys-Drash syndrome.
Zhu C; Zhao F; Zhang W; Wu H; Chen Y; Ding G; Zhang A; Huang S
Eur J Pediatr; 2013 Oct; 172(10):1357-62. PubMed ID: 23715653
[TBL] [Abstract][Full Text] [Related]
11. Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications.
Hashimoto H; Zhang X; Zheng Y; Wilson GG; Cheng X
Nucleic Acids Res; 2016 Dec; 44(21):10165-10176. PubMed ID: 27596598
[TBL] [Abstract][Full Text] [Related]
12. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites.
Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X
Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058
[TBL] [Abstract][Full Text] [Related]
13. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
[TBL] [Abstract][Full Text] [Related]
14. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
15. Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report.
Alge JL; Wenderfer SE; Hicks J; Bekheirnia MR; Schady DA; Kain JS; Braun MC
BMC Nephrol; 2017 Jul; 18(1):243. PubMed ID: 28720077
[TBL] [Abstract][Full Text] [Related]
16. A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.
Little S; Hanks S; King-Underwood L; Picton S; Cullinane C; Rapley E; Rahman N; Pritchard-Jones K
Pediatr Nephrol; 2005 Jan; 20(1):81-5. PubMed ID: 15503171
[TBL] [Abstract][Full Text] [Related]
17. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.
da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S
Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934
[TBL] [Abstract][Full Text] [Related]
18. Clinical pictures and novel mutations of WT1-associated Denys-Drash syndrome in two Chinese children.
Yue Z; Pei Y; Sun L; Huang W; Huang H; Hu B; Yang J; Jiang X; Mo Y; Chen S; Lai KN; Wang Y
Ren Fail; 2011; 33(9):910-4. PubMed ID: 21851196
[TBL] [Abstract][Full Text] [Related]
19. Focal Segmental Membranoproliferative Glomerulonephritis: A Histological Variant of Denys-Drash Syndrome.
Karmila AB; Yap YC; Appadurai M; Oh L; Fazarina M; Abd Ghani F; Ariffin H
Fetal Pediatr Pathol; 2021 Apr; 40(2):113-120. PubMed ID: 31707902
[No Abstract] [Full Text] [Related]
20. A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis.
Benetti E; Caridi G; Malaventura C; Dagnino M; Leonardi E; Artifoni L; Ghiggeri GM; Tosatto SC; Murer L
Clin J Am Soc Nephrol; 2010 Apr; 5(4):698-702. PubMed ID: 20150449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
